ÂÜÀòÂÒÂ×

Jarkko Venäläinen has extensive experience in the pharmaceutical industry, particularly in the research and development of therapies for rare neurological disorders. They have held various roles at Orion Corporation, focusing on developing novel therapies and leading teams in both CNS and rare diseases areas. With a background in biochemistry and pharmacology, Jarkko has made significant contributions in target identification, validation, and collaboration activities. Additionally, their work at the University of Eastern Finland involved leading projects aimed at developing diagnostic tools and treatments for celiac disease. Jarkko's expertise and leadership have been instrumental in advancing research and innovation in the field of healthcare.